Informace o publikaci
The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic
| Autoři | |
|---|---|
| Rok publikování | 2017 |
| Druh | Konferenční abstrakty |
| Fakulta / Pracoviště MU | |
| Citace | |
| Popis | Meeting abstract The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic. |